Advertisement

Topics

Maravai LifeSciences Company Profile

15:15 EDT 20th June 2019 | BioPortfolio

Maravai LifeSciences companies provide reagents and services to life science researchers and commercial partners to enable breakthrough discoveries and improvements in human health. Maravai’s products are used broadly by academic researchers investigating cancer and other diseases, firms developing new genetic therapies, biopharmaceutical partners validating and monitoring manufacturing processes and by OEM partners who incorporate Maravai offerings into their own products. The Maravai portfolio focuses on bioprocess impurity testing, oligonucleotide synthesis and protein detection. Maravai is a portfolio company of GTCR, a leading private equity firm focused on investing in growth companies in financial services, technology and information services and healthcare.


News Articles [117 Associated News Articles listed on BioPortfolio]

Edwards Lifesciences invests in 2 cardiac device makers

Edwards Lifesciences has made a $35 million investment in Corvia Medical and obtained the exclusive right to buy the structu -More- 

ReShape Lifesciences buys Apollo’s surgical product portfolio

Under the deal, ReShape Lifesciences has acquired surgical product line, including Lap-Band adjustable gastric banding system and other accessories used in laparoscopic bariatric surgery. Apollo has d...

Enzychem Lifesciences To Present At Biotech Showcase™ 2019 In San Francisco

ENGLEWOOD, N.J., Dec. 31, 2018 /PRNewswire/ -- Enzychem Lifesciences, a leading global biopharmaceutical company focusing on innovative new drug development for unmet medical needs, today Read more.....

Edwards Lifesciences Corp. Q1 adjusted earnings Beat Estimates

WASHINGTON (dpa-AFX) - Edwards Lifesciences Corp. (EW) announced a profit for its first quarter that rose from the same period last year.The company's profit came in at $249.7 million, or $1.18 pe...

Edwards Lifesciences invests almost $180M in Irish plant

Edwards Lifesciences has invested nearly $180 million in the construction of a new plant in Ireland, a project that is expect -More- 

$98M deal to buy CAS Medical finalized by Edwards Lifesciences

Edwards Lifesciences has announced the completion of its $98.1 million purchase of CAS Medical Systems, which makes a noninva -More- 

New patent for Genus Lifesciences drug GOPRELTO

Annual Drug Patent Expirations for GOPRELTO Goprelto is a drug marketed by Genus Lifesciences and is included in one NDA. It is available from one supplier. There are two patents… The post New paten...

The Importance of Communications in LifeSciences

In this episode of PharmaTelevision News Review Fintan Walton talks to Sue Charles & Nicole Yost of College Hill, Sharon Valdettaro from Roche & Katja Toon from AstraZeneca about the importance of co...

Drugs and Medications [2 Associated Drugs and Medications listed on BioPortfolio]

Fluconazole [baxter healthcare corporation]

Fluconazole Injection, USP For Intravenous Use Only Rx only

Ampicillin [claris lifesciences, inc.]

Ampicillin for Injection, USP for Intramuscular or Intravenous Injection Rx only

PubMed Articles [6 Associated PubMed Articles listed on BioPortfolio]

Transcatheter Aortic Valve Replacement for Alkaptonuria-Associated Aortic Stenosis.

Alkaptonuria, a rare disorder of homogentisic acid metabolism, can lead to aortic valvular calcification and stenosis. We present the case of a 71-year-old woman with alkaptonuria-associated aortic st...

Overexpansion of older generation balloon expandable transcatheter heart valves: An ex-vivo bench study.

The SAPIEN 3 (S3) transcatheter heart valve (THV) can be over-expanded beyond its labeled diameter. Overexpansion can be achieved with use of either a compliant or non-compliant balloon. Objective dat...

Versatility of endoaortic balloon occlusion device for less invasive management of complex and reoperative cardiac cases.

Heart Teams are increasingly confronted with decision-making in anatomically and clinically complex surgical candidates. Herein, we discuss the versatility of the endoaortic occlusion device (Intraclu...

Intermediate Outcomes after Rapid Deployment Aortic Valve Replacement in Multiple Valve Surgery.

 Multiple valve surgery is associated with significant higher operative risks. Reduced cross-clamp and cardiopulmonary bypass times in multiple valve surgery may potentially be beneficial as they ca...

Modified delivery of SAPIEN 3 valve in the pulmonary position: Evolution of technique or dire need?

Transcatheter pulmonary valve replacement (TPVR) is now common practice in patients with significant pulmonary regurgitation (PR), stenosis (PS), or mixed pulmonary valve disease. While the Melody val...

Clinical Trials [26 Associated Clinical Trials listed on BioPortfolio]

Safety and Effectiveness of Edwards Lifesciences SAPIEN XT THV in the Chinese Population

To evaluate the safety and effectiveness of the SAPIEN XT (Edwards Lifesciences, Irvine, California) transcatheter heart valve implantation (TAVI) in Chinese patients with symptomatic seve...

Safety and Effectiveness of Edwards Lifesciences SAPIEN 3 Transcatheter Heart Valve (THV) in the Chinese Population

To evaluate the safety and effectiveness of the SAPIEN 3 (Edwards Lifesciences, Irvine, California) transcatheter heart valve implantation (TAVI) in Chinese patients with symptomatic sever...

Edwards Lifesciences CardiAQ™ Transcatheter Mitral Valve Replacement (TMVR) Early Feasibility Study

Early feasibility study to evaluate the safety and function of the Edwards Lifesciences CardiAQ™ Transcatheter Mitral Valve

Hemodynamic Optimization During Major Abdominal Surgery

In this prospective observational study investigators aim to search any relationship between the venous to arterial carbon dioxide gap and the time of percentage to adherence too a stroke ...

The PARTNER 3 - AVIV Trial

To assess the safety and effectiveness of the SAPIEN 3 (Edwards Lifesciences, Irvine, California) transcatheter heart valve in patients with a failing aortic bioprosthetic valve.

Companies [29 Associated Companies listed on BioPortfolio]

Maravai LifeSciences

Maravai LifeSciences companies provide reagents and services to life science researchers and commercial partners to enable breakthrough discoveries and improvements in human healt...

Vedic Lifesciences Pvt. Ltd.

Vedic Lifesciences, a Phase II/III CRO, also undertakes project management of Pre-Clinical Development Services for Pharma and Biotech Companies. We have an in-house team for Medical Affairs, Regulato...

Solace Lifesciences

Solace Lifesciences, the creators of NuCalm, is a pioneer in the fields of applied neuropsychobiology and bioinformatics. Founded in 2002, the company is dedicated to improving th...

LifeSciences BC

LifeSciences BC is a not-for-profit, non-government industry association that represents and supports the biopharmaceutical, medical device, bioproducts, bioenergy and greater lif...

Edwards Lifesciences

Edwards Lifesciences Global Headquarters is located in Irvine, California, U.S.A. Our company supplies products and technologies to customers in more than 100 countries, through both direct sales and...

More Information about "Maravai LifeSciences" on BioPortfolio

We have published hundreds of Maravai LifeSciences news stories on BioPortfolio along with dozens of Maravai LifeSciences Clinical Trials and PubMed Articles about Maravai LifeSciences for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Maravai LifeSciences Companies in our database. You can also find out about relevant Maravai LifeSciences Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...


Corporate Database Quicklinks



Searches Linking to this Company Record